Maurizio Battistini is the general manager of APP Pharmaceutical Partners in Switzerland.
Manufacturing High-Potency Drugs Using Isolators
November 1st 2008The author discusses the key issues to consider when using isolators such as containment, protection of personnel, the efficiency of biodecontamination cycles, sterility assurance levels, barriers and their integrity, and environmental impact.